---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-020209"
form_type: "8-K"
ticker: "FEED"
cik: "0001326706"
company_name: "ENvue Medical, Inc."
filed_at: "2025-07-18T23:59:59+00:00"
generated_at: "2026-05-18T05:38:01.394500+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# NanoVibronix shareholders approve reverse stock split with 1:2 to 1:50 range

## Summary
- Reverse stock split amendment approved: ratio of 1-for-2 to 1-for-50, at Board discretion, within one year.
- Votes: 550,179 for, 183,224 against, 33,836 abstentions.
- Adjournment proposal approved (573,509 for, 166,066 against) but not needed.
- Special meeting held July 17, 2025; previously adjourned from July 11.

## SEC filing metadata
- accession: 0001641172-25-020209
- form_type: 8-K
- ticker: FEED
- cik: 0001326706
- company_name: ENvue Medical, Inc.
- filed_at: 2025-07-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1326706/000164117225020209/0001641172-25-020209-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1326706/000164117225020209/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-020209
- JSON: https://secwatch.observer/filing/0001641172-25-020209.json
- Plain text: https://secwatch.observer/filing/0001641172-25-020209.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.